Diagnosis of Helicobacter pylori Infection

  • Published : 2016.06.01


Helicobacter pylori infection plays an important role in the pathogenesis of chronic gastritis, peptic ulcer disease and gastric malignancy. A diagnosis of infection is thus an important part of a treatment strategy of many gastrointestinal tract diseases. Many diagnostic tests are available but all have some limitations in different clinical situations and laboratory settings. A single gold standard cannot available, but be used for diagnosis of Helicobacter pylori infection in daily clinical practice in all areas, so several techniques have been developed to give reliable results, especially focusing on real time endoscopic features. The narrow band imaging system (NBI) and high resolution endoscopy are imaging techniques for enhanced visualization of infected mucosa and premalignant gastric lesions. The aim of this article is to review the current diagnostic options and possible future developments detection of Helicobacter pylori infection.


  1. Leja M, Funka K, Janciauskas D, et al (2013). Interobserver variation in assessment of gastric premalignant lesions: higher agreement for intestinal metaplasia than for atrophy. Eur J Gastroenterol Hepatol, 25, 694-9.
  2. Lee YC, Chiu HM, Chiang TH, et al (2013). Accuracy of fecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions. BM J, 3, 7-10.
  3. Li G, WangZ, Wang Z, et al (2013). Gastric cancer patients with Helicobacter pylori infection have a poor prognosis. J Surg Oncol, 108,421-6.
  4. Masci E, Pellicano R, Mangiavillano B, et al (2014). Gastro Panel(R) test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia. Minerva Gastroenterol Dietol, 60,79-83.
  5. Oleastro M, MenardA, Santos A, et al (2003). Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J Clin Microbiol, 41, 397- 402.
  6. Burucoa C, Delchier JC, Courillon-Mallet A, et al (2013). Comparative evaluation of 29 commercial Helicobacter pylori serological kits. Helicobacter, 18, 169-79.
  7. A Bah, E Saraga, D Armstrong, et al (1995). "Endoscopic features of Helicobacter pylori-related gastritis", Endoscopy, 27, 593-6.
  8. Batts KP, Ketover S, Kakar S, et al (2013). Appropriate use of special stains for identifying Helicobacter pylori:recommendations from the rodger c. haggitt gastrointestinal pathology society. Am J Surg Pathol, 37, 12-22.
  9. Cerqueira L, Fernandes RM, Ferreira RM, et al (2013). Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens. J Clin Microbiol, 51, 1887-93.
  10. CM den Hoed, IL Holster, LG Capelle, et al (2013). Follow-up of premailignant lesions in patients at risk for progression to gastric cancer. Endoscopy, 45, 249-56.
  11. Formichella L, Romberg L, Bolz C, et al (2013). A novel line immunoassay based on recombinant virulence factors enables highly specific and sensite serologic diagnosis of Helicobacter pylori infection, Clin Vaccine Immunol, 20, 1703-10.
  12. Garcia A, Salas-Jara MJ, Herrera C, et al (2014). Biofilm and Helicobacter pylori: from environment to human host. World J Gastroenterol, 20, 5632-8.
  13. Hosseini M, Amoueian S, Attaranzadeh A, et al (2013). Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran. J Res Med Sci, 18, 225-9.
  14. Karami N, Talebkhan Y, Saberi S, et al (2013). Seroreactivity to Helicobacter pylori antigens as a risk indicator of gastric cancer. Asian Pac J Cancer Prev, 14, 1813-7.
  15. Kato T, YagiN, Kamada T, etal (2013). Diagnosis of Helicobacter pylori infection in gastric mucosa by endoscopic features: a multicenter prospective study. Dig Endosc, 25, 508-18.
  16. Kentaro Sugano, Jan Tack, Ernst J Kuipers, et al (2015). Kyoto global consensus report on Helicobacter pylori gastritis. Gut, 64, 1353-67.
  17. Khalilpour A, SanthanamA, Wei LC, et al (2013). Antigenic proteins of Helicobacter pylori of potential diagnostic value. Asian Pac J Cancer Prev, 14, 1635-42.
  18. Korkmaz H, Kesli R, Karabagli P, et al (2013). Comparison of the diagnostic accuracy of five different stool antigen tests for the diagnosis of Helicobacter pylori infection Helicobacter, 18,384-91.
  19. Patel SK, Pratap CB, Jain AK, et al (2014). Diagnosis of Helicobacter pylori: What should be the gold standard?. World J Gastroenterol, 20,12847-59.
  20. Pathak CM, Kaur B, Bhasin DK, et al (2014). Comparison of encapsulated versus nonencapsulated $^{(14)} C$-urea breath test for the detection of Helicobacter pylori infection: a scintigraphy study. Helicobacter, 19, 116-23.
  21. Peretz A, On A, Koiefman H, et al (2013). BACTEC FX system as a tool for culturing gastric biopsies and Helicobacter pylori diagnosis. Eur J Clin Microbiol Infect Dis, 32,1541-3.
  22. Rabelo-Goncalves EM, Sgardioli IC, Lopes-Cendes I, et al (2013). Improved detection of Helicobacter pylori DNA in formalin-fixed paraffin-embedded (FFPE) tissue of patients with hepatocellular carcinoma using laser capture microdissection (LCM). Helicobacter, 18, 244-5.
  23. Seo JH, Youn HS, Goo MJ, et al (2013). Recovery of Helicobacter pylori from gastric tissue cryopreserved for more than 10 years. Helicobacter, 18, 167-8.
  24. Shimoyama T (2013). Stool antigen tests for the management of Helicobacter pylori infection. World J Gastroenterol, 19,8188-91.
  25. Sugano K, Tack J, Kuipers EJ, et al (2015). Kyoto global consensus report on Helicobacter pylori gastritis. Gut, 64, 1353-67
  26. Taweesak T, Soraya K, Natthawut K, et al (2015). Correlation between gastric mucosal morphologic patterns and histopathological severity of helicobacter pylori associated gastritis using conventional narrow band imaging gastroscopy. Biamed Res Int, 7, 42-8.
  27. Taweesak T, Chavaboon D, Wilairat L, et al (2015). Improved Detection of Helicobacter pylori Infection and Premalignant Gastric Mucosa Using "Site Specific Biopsy": A Randomized Control Clinical Trial. Asian Pac J Cancer Prev, 16, 8487-90.
  28. TaweesakT, Chavalxxm D, Likit M, et al (2015). High prevalence of Helicobacter pylori resistance to clarithromycin: a hospital-based cross-sectional study in nakhon ratchasima province, northeast of Thailand. Asian Pac J Cancer Prev, 16, 8281-85.
  29. Taweesak T, Chavaboon D, Wilairat L, et al (2015). Improved Helicobacter pylori eradication rate of tailored triple therapy by adding lactobacillus delbrueckii and Streptococcus thennophilus in Northeast Region of Thailand: a prospective randomized controlled clinical Trial. Castro Res Prac, 1, 7-12.
  30. Taweesak T, Chavaooon D, Wilairat L, et al (2015). Effect of pretreatment with lactobacillus delbrueckii and streptococcus thennophillus on tailored triple therapy for Helicobacter pylori eradication: a prospective randomized controlled clinical Trial. Asian Pac J Cancer Prev, 16, 4885-90.
  31. Watanabe K, Nagata N, Shimbo T, et al (2013). Accuracy of endoscopic diagnosis of Helicobacter pylori infection according to level of endoscopic experience and the effect of training. BMC Gastroenterol, 13, 128.
  32. Yakut M, Ormeci N, Erdal H, et al (2013). The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-l Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status. Clin Res Hepatol Gastroenterol, 37, 302-11.

Cited by

  1. infection vol.21, pp.10834389, 2016,